Literature DB >> 15276534

Donor heart preservation with pinacidil: the role of the mitochondrial K ATP channel.

Michael D Diodato1, Nirav R Shah, Sunil M Prasad, Sydney L Gaynor, Jennifer S Lawton, Ralph J Damiano.   

Abstract

BACKGROUND: Pinacidil solutions have been shown to have significant cardioprotective effects. Pinacidil activates both sarcolemmal and mitochondrial potassium-adenosine triphosphate (K(ATP)) channels. This study was undertaken to compare pinacidil solution with University of Wisconsin (UW) solution and to determine if the protective effect of pinacidil involved mitochondrial or sarcolemmal K(ATP) channels.
METHODS: Thirty-two rabbit hearts received one of four preservation solutions in a Langendorff apparatus: (1) UW; (2) a solution containing 0.5 mmol/L pinacidil; (3) pinacidil with Hoechst-Marion-Roussel 1098 (HMR-1098), a sarcolemmal channel blocker; and (4) pinacidil with 5-hydroxydecanote, a mitochondrial channel blocker. Left ventricular pressure-volume curves were generated by an intraventricular balloon. All hearts were placed in cold storage for 8 hours, followed by 60 minutes of reperfusion.
RESULTS: Postischemic developed pressure was better preserved by pinacidil than by UW. This cardioprotective effect was eliminated by 5-hydroxydecanote and diminished by HMR-1098. Diastolic compliance was better preserved by pinacidil when compared with UW. This protection was abolished by the addition of 5-hydroxydecanote and moderately decreased by HMR-1098.
CONCLUSIONS: Our results support the superiority of pinacidil over UW after 8 hours of storage. The cardioprotective role of pinacidil is mediated primarily by the mitochondrial K(ATP) channel.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15276534     DOI: 10.1016/j.athoracsur.2004.02.097

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  2 in total

1.  Cardioprotective benefits of adenosine triphosphate-sensitive potassium channel opener diazoxide are lost with administration after the onset of stress in mouse and human myocytes.

Authors:  M Burhan Janjua; Carol M Makepeace; Melissa M Anastacio; Richard B Schuessler; Colin G Nichols; Jennifer S Lawton
Journal:  J Am Coll Surg       Date:  2014-06-03       Impact factor: 6.113

2.  HMR 1098 is not an SUR isotype specific inhibitor of heterologous or sarcolemmal K ATP channels.

Authors:  Hai Xia Zhang; Alejandro Akrouh; Harley T Kurata; Maria Sara Remedi; Jennifer S Lawton; Colin G Nichols
Journal:  J Mol Cell Cardiol       Date:  2010-12-23       Impact factor: 5.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.